A signal-to-cutoff ratio in the abbott architect HIV Ag/Ab combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting

Journal of Clinical Microbiology

Volumn 53, Issue 5, 2015, Pages 1709-1711

  Jensen, Tomas Ostergaard ^a,b   Robertson, Peter ^a   Whybin, Ross ^a   Chambers, Ian ^c   Lahra, Monica ^a   Rawlinson, William ^a   Post, Jeffrey John ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Douglass Hanly Moir Pathology   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHEMICAL PARAMETERS; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HIV CLIA KIT; HIV RAPID TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PREDICTION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SIGNAL TO CUTOFF RATIO; WESTERN BLOTTING; ADULT; BLOOD; EVALUATION STUDY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; SEROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ADULT; FEMALE; HIV ANTIBODIES; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 84928036804     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03583-14     Document Type: Article

References (18)

1. Chavez P, Wesolowski L, Patel P, Delaney K, Owen SM. 2011. Evaluation of the performance of the Abbott Architect HIV Ag/Ab Combo assay. J Clin Virol 52(Suppl):S51-55. http://dx.doi.org/10.1016/j.jcv.2011 .09.010.
2. Kwon J-A, Yoon S-Y, Lee C-K, Lim CS, Lee KN, Sung HJ, Brennan CA, Devare SG. 2006. Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays. J Virol Methods 133:20-26. http://dx.doi.org/10.1016/j.jviromet.2005.10 .013.
3. Song EY, Hur M, Roh EY, Park MH, Moon H-W, Yun YM. 2012. Performances of four fourth-generation human immunodeficiency virus-1 screening assays. J Med Virol 84:1884-1888. http://dx.doi.org/10 .1002/jmv.23423.
4. Centers for Disease Control and Prevention. 2014. Laboratory testing for the diagnosis of HIV infection: updated recommendations. Centers for Disease Control and Prevention, Atlanta, GA.
5. The Kirby Institute. 2014. HIV, viral hepatitis and sexually transmissible infections in Australia. Annual Surveillance Report 2014. University of New South Wales, Sydney, Australia.
6. Acar A, Kemahli S, Altunay H, Kosan E, Oncul O, Gorenek L, Cavuslu S. 2010. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing. Transfus Med 20:152-159. http://dx.doi.org/10.1111/j.1365-3148.2009.00987.x.
7. Brennan CA, Yamaguchi J, Vallari A, Swanson P, Hackett JR, Jr. 2013. Architect HIV Ag/Ab Combo assay: correlation of HIV-1 p24 antigen sensitivity and RNA viral load using genetically diverse virus isolates. J Clin Virol 57:169-172. http://dx.doi.org/10.1016/j.jcv.2013.01.017.
8. Kim S, Lee J-H, Choi JY, Kim JM, Kim H-S. 2010. False-positive rate of a "fourth-generation" HIV antigen/antibody combination assay in an area of low HIV prevalence. Clin Vaccine Immunol 17:1642-1644. http://dx .doi.org/10.1128/CVI.00258-10.
9. Albritton WL, Vittinghoff E, Padian NS. 1996. Human immunodeficiency virus testing for patient-based and population-based diagnosis. J Infect Dis 174:S176-S181. http://dx.doi.org/10.1093/infdis/174.Supplement-2.S176.
10. Daar ES, Little S, Pitt J, Santangelo J, Ho P, Harawa N, Kerndt P, Glorgi JV, Bai J, Gaut P, Richman DD, Mandel S, Nichols S. 2001. Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network. Ann Intern Med 134:25-29. http://dx.doi.org/10 .7326/0003-4819-134-1-200101020-00010.
11. Elavia AJ, Thomas A, Nandi J, Coyaji GD, Bhavalkar-Potdar V. 1995. Performance evaluation of a particle agglutination test for antibody to human immunodeficiency virus 1: comparison with enzyme immunoassay. Vox Sang 69:23-26. http://dx.doi.org/10.1111/j.1423-0410.1995 .tb00343.x.
12. Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. 2002. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 16:1119-1129. http://dx.doi.org/10.1097/00002030-200205240-00005.
13. Lee BE, Plitt SS, Jayaraman GC, Chui L, Singh AE, Preiksaitis JK. 2012. Use of quantitative HIV RNA detection for early diagnosis of HIV infection in infants and acute HIV infections in Alberta, Canada. J Clin Microbiol 50:502-505. http://dx.doi.org/10.1128/JCM.05471-11.
14. Lyamuya E, Bredberg-Radén U, Massawe A, Urassa E, Kawo G, Msemo G, Kazimoto T, Ostborn A, Karlsson K, Mhalu F, Biberfeld G. 1996. Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr Hum Retrovirol 12:421-426. http://dx.doi.org/10.1097/00042560-19960 8010-00014.
15. Nadal D, Böni J, Kind C, Varnier OE, Steiner F, Tomasik Z, Schüpbach J. 1999. Prospective evaluation of amplification-boosted ELISA for heatdenatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection. J Infect Dis 180:1089-1095. http://dx.doi.org/10.1086/315012.
16. Nesheim S, Palumbo P, Sullivan K, Lee F, Vink P, Abrams E, Bulterys M. 2003. Quantitative RNA testing for diagnosis of HIV-infected infants. J Acquir Immune Defic Syndr 32:192-195.
17. Owen SM, Yang C, Spira T, Ou CY, Pau CP, Parekh BS, Candal D, Kuehl D, Kennedy MS, Rudolph D, Luo W, Delatorre N, Masciotra S, Kalish ML, Cowart F, Barnett T, Lal R, McDougal JS. 2008. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol 46:1588-1595. http://dx.doi.org/10.1128/JCM.02196-07.
18. Schüpbach J, Böni J, Tomasik Z, Jendis J, Seger R, Kind C. 1994. Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human immunodeficiency virus type 1-infected infants. Swiss Neonatal HIV Study Group. J Infect Dis 170:318-324.